Lotus Eye Hospital and Institute Management
Management criteria checks 4/4
Lotus Eye Hospital and Institute's CEO is Kuttapalayam Ramalingam, appointed in Aug 2020, has a tenure of 4.5 years. directly owns 1.43% of the company’s shares, worth ₹19.77M. The average tenure of the management team and the board of directors is 4.4 years and 4.1 years respectively.
Key information
Kuttapalayam Ramalingam
Chief executive officer
₹1.2m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 4.5yrs |
| CEO ownership | 1.4% |
| Management average tenure | 4.4yrs |
| Board average tenure | 4.1yrs |
Recent management updates
Recent updates
Optimistic Investors Push Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) Shares Up 25% But Growth Is Lacking
Aug 21
Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) Price Is Out Of Tune With Earnings
Jan 24Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50
Sep 08We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease
Jul 15Here's Why Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Has Caught The Eye Of Investors
Apr 07We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease
Oct 08Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50
Sep 02If EPS Growth Is Important To You, Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Presents An Opportunity
Jun 17MD & Whole Time Director Sangeetha Sundaramoorthy Just Bought 2.8% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
Mar 11Chief Executive Officer K. Ramalingam Just Bought 122% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
Dec 30Insider Buying: The Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) MD & Whole Time Director Just Bought 2.8% More Shares
Nov 20The Chief Executive Officer of Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE), K. Ramalingam, Just Bought 17% More Shares
Sep 21Why Investors Shouldn't Be Surprised By Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) P/E
Aug 27
Should You Take Comfort From Insider Transactions At Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)?
Aug 03Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) P/E Isn't Throwing Up Surprises
Jul 06CEO
Kuttapalayam Ramalingam (74 yo)
4.5yrs
Tenure
₹1,200,000
Compensation
Dr. Kuttapalayam Songappan Ramalingam, M.D., serves as an Executive Director at Lotus Eye Hospital and Institute Limited since February 10, 2021. Dr. Ramalingam serves as Chief Executive Officer at Lotus E...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 4.5yrs | ₹1.20m | 1.43% ₹ 19.8m | |
| Chief Financial Officer | 2.8yrs | ₹1.70m | no data | |
| Company Secretary & Compliance Officer | 3yrs | ₹1.08m | no data | |
| MD & Director | 4.4yrs | ₹3.09m | 18.84% ₹ 259.6m | |
| Vice President of Administration | 6.8yrs | no data | 0% ₹ 0 |
4.4yrs
Average Tenure
67yo
Average Age
Experienced Management: LOTUSEYE's management team is considered experienced (4.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 4yrs | ₹1.20m | 1.43% ₹ 19.8m | |
| MD & Director | 5.3yrs | ₹3.09m | 18.84% ₹ 259.6m | |
| Vice President of Administration | 5.1yrs | no data | 0% ₹ 0 | |
| Chairman of the Board | 8.8yrs | ₹150.00k | 18.78% ₹ 258.7m | |
| Independent Director | 4.1yrs | ₹200.00k | no data | |
| Independent Non-Executive Director | 2.2yrs | ₹200.00k | no data | |
| Independent Non-Executive Director | 2yrs | ₹175.00k | no data |
4.1yrs
Average Tenure
61yo
Average Age
Experienced Board: LOTUSEYE's board of directors are considered experienced (4.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/01 20:37 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Lotus Eye Hospital and Institute Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|